We are live on ! Find out more
CU

CDAM (UK) Portfolio holdings

AUM $387M Turnover 8.33%
1-Year Est. Return 4.05%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
-4.05%
3 Year Est. Return
+7.89%
5 Year Est. Return
+3.79%
10 Year Est. Return
–
AUM
$387M
AUM Growth
-$63.5M
Cap. Flow
-$100M
Cap. Flow %
-25.82%
Top 10 Hldgs %
93.22%
Holding
12
New
1
Increased
1
Reduced
10
Closed
–
Avg Time Held
3.7 years
Top 10 Avg Time Held
3 years
Top 20 Avg Time Held
3.7 years

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$18.7M
2
EFX icon
Equifax
EFX
+$9.7M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$34.5M
2
QLYS icon
Qualys
QLYS
+$24.5M
3
TFII icon
TFI International
TFII
+$19.8M
4
CNM icon
Core & Main
CNM
+$12.1M
5
CIGI icon
Colliers International
CIGI
+$9.6M

Sector Composition

Rank Sector Weight
1 Industrials 30.52%
2 Technology 19.67%
3 Healthcare 14.81%
4 Consumer Discretionary 11.93%
5 Real Estate 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CNM icon
1
Core & Main
CNM
$7.67B
$49.1M 12.68%
1,017,772
-245,475
-19% -$12.1M
2024 Q1
9 quarters
LGIH icon
2
LGI Homes
LGIH
$973M
$46.2M 11.93%
725,470
-174,761
-19% -$8.35M
2018 Q4
30 quarters
NOW icon
3
ServiceNow
NOW
$149B
$39.3M 10.14%
395,457
-38,302
-9% -$3.79M
2022 Q2
16 quarters
VEEV icon
4
Veeva Systems
VEEV
$51.4B
$37.8M 9.77%
213,248
-52,006
-20% -$8.58M
2025 Q1
5 quarters
CIGI icon
5
Colliers International
CIGI
$4.55B
$37.2M 9.6%
396,422
-95,602
-19% -$9.6M
2020 Q1
25 quarters
TFII icon
6
TFI International
TFII
$9.19B
$36.5M 9.43%
254,560
-139,999
-35% -$19.8M
2022 Q3
15 quarters
EFX icon
7
Equifax
EFX
$18.7B
$32.6M 8.41%
205,288
+56,818
+38% +$9.7M
2026 Q1
1 quarter
QLYS icon
8
Qualys
QLYS
$6.49B
$30.2M 7.8%
219,862
-249,139
-53% -$24.5M
2020 Q1
25 quarters
CRH icon
9
CRH
CRH
$55B
$28.4M 7.34%
265,665
-313,830
-54% -$34.5M
2025 Q1
5 quarters
ZD icon
10
Ziff Davis
ZD
$1.95B
$23.7M 6.13%
453,502
-110,165
-20% -$4.98M
2021 Q3
19 quarters
TMO icon
11
Thermo Fisher Scientific
TMO
$250B
$19.5M 5.04%
+38,960
New +$18.7M
2026 Q2
0 quarters
DAVA icon
12
Endava
DAVA
$107M
$6.72M 1.73%
2,374,626
-574,946
-19% -$2.12M
2019 Q2
28 quarters

Similar funds

CDAM (UK)'s Q2 2026 Portfolio in Review

As of Q2 2026, CDAM (UK) held 12 positions worth $387M, down 14% from $451M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

CDAM (UK) withdrew a net $100M in Q2 2026, reducing 10 holdings. Its largest reduction was CRH, cutting an estimated $34.5M.

By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, CDAM (UK) opened a new position in Thermo Fisher Scientific worth $19.5M.

  • CDAM (UK)'s largest Q2 2026 buy was Thermo Fisher Scientific: 38,960 shares worth $19.5M.
  • CDAM (UK) added most to Equifax in Q2 2026, an estimated $9.7M increase.
  • CDAM (UK)'s biggest Q2 2026 reduction was CRH, cutting an estimated $34.5M.
  • CDAM (UK)'s ten largest holdings make up 93% of its $387M portfolio in Q2 2026.
  • CDAM (UK) opened 1 new position and closed 0 in Q2 2026.
  • CDAM (UK)'s portfolio value fell 14% quarter-over-quarter to $387M.

Based on CDAM (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.